These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35884060)

  • 1. Acupuncture for Pain Management in Pediatric Patients with Sickle Cell Disease.
    Plonski KS
    Children (Basel); 2022 Jul; 9(7):. PubMed ID: 35884060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-Dose Ketamine Infusion for Adjunct Management during Vaso-occlusive Episodes in Adults with Sickle Cell Disease: A Case Series.
    Palm N; Floroff C; Hassig TB; Boylan A; Kanter J
    J Pain Palliat Care Pharmacother; 2018 Mar; 32(1):20-26. PubMed ID: 29791238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine use for management of vaso-occlusive pain in pediatric sickle cell disease.
    Harris EM; Vilk E; Donado C; Williams A; Heeney MM; Solodiuk J; Greco C; Archer NM
    Pediatr Blood Cancer; 2023 May; 70(5):e30254. PubMed ID: 36861789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketamine for Sickle Cell Vaso-Occlusive Crises: A Systematic Review.
    Alshahrani MS; Alghamdi MA
    Saudi J Med Med Sci; 2021; 9(1):3-9. PubMed ID: 33519337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: a randomized controlled trial.
    Lubega FA; DeSilva MS; Munube D; Nkwine R; Tumukunde J; Agaba PK; Nabukenya MT; Bulamba F; Luggya TS
    Scand J Pain; 2018 Jan; 18(1):19-27. PubMed ID: 29794277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fentanyl Buccal Tablet: A New Breakthrough Pain Medication in Early Management of Severe Vaso-Occlusive Crisis in Sickle Cell Disease.
    De Franceschi L; Mura P; Schweiger V; Vencato E; Quaglia FM; Delmonte L; Evangelista M; Polati E; Olivieri O; Finco G
    Pain Pract; 2016 Jul; 16(6):680-7. PubMed ID: 26009799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pain management in children with sickle cell disease.
    Stinson J; Naser B
    Paediatr Drugs; 2003; 5(4):229-41. PubMed ID: 12662119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of ketamine for the management of vaso-occlusive pain in sickle cell disease.
    Harris EM; Vilk E; Heeney MM; Solodiuk J; Greco C; Archer NM
    Pediatr Blood Cancer; 2021 Jul; 68(7):e28989. PubMed ID: 33788404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute kidney injury during a pediatric sickle cell vaso-occlusive pain crisis.
    Baddam S; Aban I; Hilliard L; Howard T; Askenazi D; Lebensburger JD
    Pediatr Nephrol; 2017 Aug; 32(8):1451-1456. PubMed ID: 28238158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient characteristics affect the response to ketamine and opioids during the treatment of vaso-occlusive episode-related pain in sickle cell disease.
    Nobrega R; Sheehy KA; Lippold C; Rice AL; Finkel JC; Quezado ZMN
    Pediatr Res; 2018 Feb; 83(2):445-454. PubMed ID: 28902183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease.
    Puri L; Nottage KA; Hankins JS; Anghelescu DL
    Paediatr Drugs; 2018 Feb; 20(1):29-42. PubMed ID: 28853040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of adenotonsillectomy in reducing obstructive sleep apnea, cerebrovascular ischemia, vaso-occlusive pain, and ACS episodes in pediatric sickle cell disease.
    Tripathi A; Jerrell JM; Stallworth JR
    Ann Hematol; 2011 Feb; 90(2):145-50. PubMed ID: 20714723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaso-occlusive crisis in sickle cell disease: current paradigm on pain management.
    Uwaezuoke SN; Ayuk AC; Ndu IK; Eneh CI; Mbanefo NR; Ezenwosu OU
    J Pain Res; 2018; 11():3141-3150. PubMed ID: 30588066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective review of acupuncture use for the treatment of pain in sickle cell disease patients: descriptive analysis from a single institution.
    Lu K; Cheng MC; Ge X; Berger A; Xu D; Kato GJ; Minniti CP
    Clin J Pain; 2014 Sep; 30(9):825-30. PubMed ID: 24322996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sickle cell disease pain management in adolescents: a literature review.
    Wilson BH; Nelson J
    Pain Manag Nurs; 2015 Apr; 16(2):146-51. PubMed ID: 25175555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Interrupted Time Series Analysis of the Dissemination of a Sickle Cell Vaso-Occlusive Episode Treatment Algorithm and a Case Management Referral Form for Individuals With Sickle Cell Disease in the Emergency Department.
    Bulgin D; Bonnabeau E; Alexander A; Frederick E; Rains G; Shah N; Young M; Tanabe P
    J Emerg Nurs; 2021 Jan; 47(1):40-49.e1. PubMed ID: 32826064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subdissociative intranasal ketamine plus standard pain therapy versus standard pain therapy in the treatment of paediatric sickle cell disease vaso-occlusive crises in resource-limited settings: study protocol for a randomised controlled trial.
    Young JR; Sawe HR; Mfinanga JA; Nshom E; Helm E; Moore CG; Runyon MS; Reynolds SL
    BMJ Open; 2017 Jul; 7(7):e017190. PubMed ID: 28698351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.
    Casella JF; Barton BA; Kanter J; Black LV; Majumdar S; Inati A; Wali Y; Drachtman RA; Abboud MR; Kilinc Y; Fuh BR; Al-Khabori MK; Takemoto CM; Salman E; Sarnaik SA; Shah N; Morris CR; Keates-Baleeiro J; Raj A; Alvarez OA; Hsu LL; Thompson AA; Sisler IY; Pace BS; Noronha SA; Lasky JL; de Julian EC; Godder K; Thornburg CD; Kamberos NL; Nuss R; Marsh AM; Owen WC; Schaefer A; Tebbi CK; Chantrain CF; Cohen DE; Karakas Z; Piccone CM; George A; Fixler JM; Singleton TC; Moulton T; Quinn CT; de Castro Lobo CL; Almomen AM; Goyal-Khemka M; Maes P; Emanuele M; Gorney RT; Padgett CS; Parsley E; Kronsberg SS; Kato GJ; Gladwin MT
    JAMA; 2021 Apr; 325(15):1513-1523. PubMed ID: 33877274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acupuncture for pain management in children with sickle cell disease.
    Mahmood LA; Reece-Stremtan S; Idiokitas R; Martin B; Margulies S; Hardy SJ; Bost JE; Darbari DS
    Complement Ther Med; 2020 Mar; 49():102287. PubMed ID: 32147045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.
    Ender KL; Krajewski JA; Babineau J; Tresgallo M; Schechter W; Saroyan JM; Kharbanda A
    Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.